Ignite Creation Date:
2025-12-24 @ 9:49 PM
Ignite Modification Date:
2026-01-02 @ 10:43 AM
Study NCT ID:
NCT00971932
Status:
COMPLETED
Last Update Posted:
2014-04-08
First Post:
2009-09-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Sponsor:
Merck KGaA, Darmstadt, Germany
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-07
Start Date Type:
None
Primary Completion Date:
2011-03
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2009-09-03
First Submit QC Date:
None
Study First Post Date:
2009-09-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-07-04
Results First Submit QC Date:
None
Results First Post Date:
2012-08-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-03-10
Last Update Post Date:
2014-04-08
Last Update Post Date Type:
ESTIMATED